Ruiting Li Selected Research

Ruiting Li Research Topics

Disease

9	Neoplasms (Cancer) 03/2024 - 07/2017
8	COVID-19 01/2022 - 01/2020
7	Acute Lung Injury 10/2020 - 01/2019
6	Sepsis (Septicemia) 03/2024 - 10/2020
6	Infections 01/2023 - 01/2019
6	Inflammation (Inflammations) 01/2023 - 01/2018
5	Critical Illness (Critically Ill) 01/2024 - 01/2020
5	Body Weight (Weight, Body) 09/2023 - 04/2016
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024 - 01/2020
4	Asthma (Bronchial Asthma) 01/2023 - 01/2018
4	Carotid Artery Injuries 01/2021 - 01/2019
3	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 01/2020
3	Hyperplasia 01/2021 - 10/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024 - 01/2023
2	Hypotension (Low Blood Pressure) 12/2023 - 11/2022
2	Bites and Stings (Sting) 11/2023 - 01/2023
2	Mucopolysaccharidosis I (Hurler Syndrome) 02/2023 - 06/2022
2	Respiratory Hypersensitivity 01/2023 - 01/2020
2	Lymphoma (Lymphomas) 01/2023 - 01/2020
2	Hypoxia (Hypoxemia) 11/2022 - 10/2022
2	Hemorrhage 05/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
2	Atherosclerosis 12/2021 - 10/2021
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 04/2021 - 01/2021
1	Paresthesia (Dysesthesia) 03/2024
1	Propofol Infusion Syndrome 03/2024
1	Hypertriglyceridemia 03/2024
1	Prostatic Neoplasms (Prostate Cancer) 03/2024
1	Cardiogenic Shock 01/2024
1	Shock 01/2024
1	Septic Shock (Toxic Shock Syndrome) 01/2024
1	Pneumonia (Pneumonitis) 11/2023

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2018
8	HMGB1 Protein (HMG1)IBA 01/2023 - 01/2018
8	CytokinesIBA 01/2023 - 01/2020
5	InflammasomesIBA 11/2023 - 01/2018
3	InterleukinsIBA 11/2023 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2021
3	VaccinesIBA 01/2022 - 01/2021
2	Propofol (Diprivan)FDA LinkGeneric 03/2024 - 12/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 09/2023
2	remimazolamIBA 12/2023 - 11/2022
2	InterferonsIBA 11/2023 - 04/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 01/2020
2	LipopolysaccharidesIBA 11/2023 - 10/2020
2	EnzymesIBA 11/2023 - 02/2023
2	Adenine FDA LinkGeneric 03/2023 - 02/2023
2	Iduronidase (alpha-L-Iduronidase)IBA 02/2023 - 06/2022
2	AlbuminsIBA 01/2023 - 01/2022
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2022 - 01/2019
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2021 - 04/2019
2	CholesterolIBA 12/2021 - 03/2020
2	erucylphosphocholineIBA 01/2021 - 01/2019
2	AntibodiesIBA 12/2020 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 10/2020 - 01/2020
2	plerixafor FDA Link 10/2020 - 10/2020
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2018
1	daratumumabIBA 04/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2024
1	venetoclaxIBA 04/2024
1	Etoposide (VP 16)FDA LinkGeneric 04/2024
1	AclarubicinIBA 04/2024
1	fospropofol FDA Link 03/2024
1	ProdrugsIBA 03/2024
1	snake venom protein C activatorIBA 03/2024
1	Androgen Receptors (Androgen Receptor)IBA 03/2024
1	NucleotidesIBA 11/2023
1	Sirolimus (Rapamycin)FDA Link 11/2023
1	enhanced green fluorescent proteinIBA 11/2023
1	Bovine Serum AlbuminIBA 11/2023
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 11/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2023
1	Interferon Type IIBA 11/2023
1	NF-kappa B (NF-kB)IBA 11/2023
1	Polysorbates (PSML)FDA Link 11/2023
1	ImmunosorbentsIBA 11/2023
1	Oxidoreductases (Dehydrogenase)IBA 11/2023
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2023
1	Phosphotransferases (Kinase)IBA 11/2023
1	NLR ProteinsIBA 11/2023
1	Phosphates (Orthophosphate)IBA 11/2023
1	polyvinylidene fluoride (PVDF)IBA 11/2023
1	Hematoxylin (Haematoxylon)IBA 11/2023

Therapy/Procedure

5	Therapeutics 03/2024 - 07/2017
4	Extracorporeal Membrane Oxygenation 01/2024 - 01/2020
3	Oral Administration 03/2024 - 01/2020
2	Salvage Therapy 04/2024 - 01/2024
2	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2020
2	Immunotherapy 01/2022 - 04/2021
2	Drug Therapy (Chemotherapy) 01/2019 - 07/2017
1	CAG protocol 04/2024
1	Catheters 03/2024
1	Castration 03/2024
1	Deep Sedation 12/2023
1	Punctures 11/2023
1	Ligation 11/2023